By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Postfach 103780

Heidelberg    69027  Germany
Phone: 49-0-6221-4038-0 Fax: 49-0-6221-4038-101



Company News
SYGNIS Pharma AG Presents Its First Own Product Line Based On PrimPol Technology: TruePrime 11/20/2014 11:15:32 AM
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014 1:33:08 PM
SYGNIS Pharma AG’ New TthPrimPol Polymerase Took Centre Stage At Zing DNA Polymerases Conference 2014 9/22/2014 12:37:25 PM
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014 2:08:05 PM
GBC Research Reiterates "BUY" Recommendation On SYGNIS Pharma AG With A Price Target Of EUR6.00 4/16/2014 10:01:01 AM
First SYGNIS Pharma AG QualiPhi® -Based Products Launched By QIAGEN Inc. (QGEN) 2/12/2014 1:36:29 PM
SYGNIS Pharma AG Capital Increase Oversubscribed At Final Closing 12/18/2013 1:31:50 PM
SYGNIS Pharma AG Secures Further Financial Resources With New Investors Loan 7/8/2013 9:29:55 AM
SYGNIS Pharma AG Announces Management Board Changes 3/26/2013 9:44:54 AM
SYGNIS Pharma AG to Discontinue Ongoing R&D Project, Trim Workforce 12/20/2012 6:40:05 AM